Ensemble and Penelope Health Partner to Identify Coverage Requirements Before Care

Ensemble Health Partners is partnering with Penelope Health to integrate real-time payer policy intelligence into its revenue cycle management platform, with the aim of helping healthcare providers identify insurance coverage requirements before care is delivered. The collaboration is intended to shift claim denial management toward prevention by making insurers’ clinical policies and payment requirements easier to access and apply.

The integration will combine Penelope’s structured information on published payer policies with Ensemble’s data on how insurers assess and adjudicate claims. The companies plan to apply this intelligence to prior authorizations, denial prevention, billing, and appeals, allowing healthcare organizations to identify potential reimbursement issues earlier in the process.

Organizing Fragmented Clinical Policies

Payer coverage requirements are spread across different sources and formats, making them difficult for providers to locate and interpret. This can leave healthcare organizations discovering relevant requirements only after an insurance claim has been denied.

Penelope Health’s platform brings information from different insurance coverage rules and payment policies into a single structured reference. Its database provides access to policies covering more than 200 million Americans and includes over 15,000 procedure and drug codes.

Through the integration, Ensemble intends to incorporate continuously updated policy information into its existing decision-support capabilities. The information is expected to help its teams assess changes in payer requirements, identify potential reimbursement problems, and support appeals by enabling providers to reference specific rules when challenging an insurer’s decision.

Applying Policy Intelligence to Revenue Cycle Workflows

Ensemble manages end-to-end revenue cycle operations for health systems, including more than 200 hospitals and over $55 billion in net patient revenue. Its platform covers patient access, coding, claims management, denial prevention, accounts receivable follow-up, and the patient financial experience.

The partnership will bring Penelope’s published policy information into these operations, while Ensemble’s claims data will provide insight into how insurers apply their stated requirements in practice. Penelope will also draw on Ensemble’s operational experience and revenue cycle expertise to develop its platform for health systems nationwide.

Judson Ivy, Ensemble’s founder and CEO, said the integration would add a real-time view of clinical policies to the company’s existing intelligence capabilities. He identified fewer denials, faster authorizations, and stronger appeals as intended benefits for the health systems using the platform.

Jim Gaffney, Ensemble’s chief strategy officer, highlighted the role of transparency in reducing administrative difficulties. “One of the largest problems that causes most friction is a lack of transparency of the rules that everyone’s using to approve and pay for care,” he told Fierce Healthcare.

Thoreau’s Investments and Wider Technology Efforts

The partnership is one of the initial platform collaborations associated with Thoreau, a healthcare investment platform founded by private equity executive Matt Holt. In June, Thoreau agreed to become Ensemble’s controlling shareholder in a deal reportedly valuing the company at $12 billion.

In September, Thoreau and other investors committed $100 million to Penelope Health to support its development of shared infrastructure for healthcare payment and clinical rules.

Ensemble also announced a partnership with enterprise AI company Cohere in March to develop a large language model specifically designed for healthcare financial workflows.

The collaboration takes place as the Centers for Medicare & Medicaid Services pursues measures intended to improve prior authorization transparency, accelerate decision timeframes, and reduce administrative burdens for patients and providers. Gaffney said the companies were working to make coverage requirements clearer rather than waiting for every payer to provide all relevant information.